Significantly Higher Peripheral Insulin-Like Growth Factor-1 Levels in Patients With Major Depressive Disorder or Bipolar Disorder Than in Healthy Controls: A Meta-Analysis and Review Under Guideline of PRISMA

An increasing amount of research has focused on insulin-like growth factor-1 (IGF-1) because of multiple neurotrophic effects, including neurogenesis, remyelination, and synaptogenesis. In addition, IGF-1 can mediate an antidepressant effect in patients with major affective disorder, and its levels...

Descripción completa

Detalles Bibliográficos
Autores principales: Tu, Kun-Yu, Wu, Ming-Kung, Chen, Yen-Wen, Lin, Pao-Yen, Wang, Hung-Yu, Wu, Ching-Kuan, Tseng, Ping-Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
5000
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291552/
https://www.ncbi.nlm.nih.gov/pubmed/26825882
http://dx.doi.org/10.1097/MD.0000000000002411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291552/
https://www.ncbi.nlm.nih.gov/pubmed/26825882
http://dx.doi.org/10.1097/MD.0000000000002411

Ejemplares similares